Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of K Cells market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of K Cellsmarket, defines the market attractiveness level of K Cells market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of K Cells industry, describes the types of K Cells market, the applications of major players and the market size, and deeply analyzes the current situation of the global K Cells market and the development prospects and opportunities of K Cells industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global K Cells market in Chapter 13.
By Player:
Takeda Pharmaceutical (Japan)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
NantKwest Inc (USA)
Sorrento Therapeutics Inc (USA)
By Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
By End-User:
Cancer
Cardiovascular Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 K Cells Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 K Cells Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 K Cells Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 K Cells Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise K Cells Market Analysis and Outlook to 2022
-
7.1 Global K Cells Consumption (2017-2022)
-
7.2 United States K Cells Consumption (2017-2022)
-
7.3 Europe K Cells Consumption (2017-2022)
-
7.4 China K Cells Consumption (2017-2022)
-
7.5 Japan K Cells Consumption (2017-2022)
-
7.6 India K Cells Consumption (2017-2022)
-
7.7 South Korea K Cells Consumption (2017-2022)
8 Region and Country-wise K Cells Market Analysis and Outlook to 2028
-
8.1 Global K Cells Consumption Forecast (2022-2028)
-
8.2 United States K Cells Consumption Forecast (2022-2028)
-
8.3 Europe K Cells Consumption Forecast (2022-2028)
-
8.4 China K Cells Consumption Forecast (2022-2028)
-
8.5 Japan K Cells Consumption Forecast (2022-2028)
-
8.6 India K Cells Consumption Forecast (2022-2028)
-
8.7 South Korea K Cells Consumption Forecast (2022-2028)
9 Global K Cells Market Outlook by Types and Applications to 2022
-
9.1 Global K Cells Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global K Cells Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global K Cells Market Outlook by Types and Applications to 2028
-
10.1 Global K Cells Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global K Cells Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global K Cells Import and Export Analysis (Top 5 Countries)
-
11.1 Global K Cells Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global K Cells Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 K Cells Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global K Cells Market Competitive Analysis
-
14.1 Takeda Pharmaceutical (Japan)
-
14.1.1 Takeda Pharmaceutical (Japan) Company Details
-
14.1.2 Takeda Pharmaceutical (Japan) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceutical (Japan) K Cells Product and Service
-
14.2 Bristol-Myers Squibb (USA)
-
14.2.1 Bristol-Myers Squibb (USA) Company Details
-
14.2.2 Bristol-Myers Squibb (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb (USA) K Cells Product and Service
-
14.3 NKT Therapeutics (USA)
-
14.3.1 NKT Therapeutics (USA) Company Details
-
14.3.2 NKT Therapeutics (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 NKT Therapeutics (USA) K Cells Product and Service
-
14.4 NantKwest Inc (USA)
-
14.4.1 NantKwest Inc (USA) Company Details
-
14.4.2 NantKwest Inc (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 NantKwest Inc (USA) K Cells Product and Service
-
14.5 Sorrento Therapeutics Inc (USA)
-
14.5.1 Sorrento Therapeutics Inc (USA) Company Details
-
14.5.2 Sorrento Therapeutics Inc (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sorrento Therapeutics Inc (USA) K Cells Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of K Cells
-
Figure K Cells Picture
-
Table Global K Cells Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global K Cells Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global K Cells Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global K Cells Consumption by Country (2017-2022)
-
Figure United States K Cells Consumption and Growth Rate (2017-2022)
-
Table Europe K Cells Consumption and Growth Rate (2017-2022)
-
Figure China K Cells Consumption and Growth Rate (2017-2022)
-
Figure Japan K Cells Consumption and Growth Rate (2017-2022)
-
Figure India K Cells Consumption and Growth Rate (2017-2022)
-
Figure South Korea K Cells Consumption and Growth Rate (2017-2022)
-
Figure Global K Cells Consumption Forecast by Country (2022-2028)
-
Figure United States K Cells Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe K Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure China K Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan K Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure India K Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea K Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global K Cells Import by Region (Top 5 Countries) (2017-2028)
-
Table Global K Cells Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceutical (Japan) (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical (Japan) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical (Japan) K Cells Product and Service
-
Table Bristol-Myers Squibb (USA) (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb (USA) K Cells Product and Service
-
Table NKT Therapeutics (USA) (Foundation Year, Company Profile and etc.)
-
Table NKT Therapeutics (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table NKT Therapeutics (USA) K Cells Product and Service
-
Table NantKwest Inc (USA) (Foundation Year, Company Profile and etc.)
-
Table NantKwest Inc (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table NantKwest Inc (USA) K Cells Product and Service
-
Table Sorrento Therapeutics Inc (USA) (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Inc (USA) K Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Inc (USA) K Cells Product and Service
-
